This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference. I discuss: Identifying generic entry opportunities at the earliest stages Discovering opportunities that avoid litigation…
The post Generic Portfolio Manage…
Generic Portfolio Management, Partnering with Brands, and Staying Competitive Read Post »
We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…
The post Thinking of signing your company up for Dr…
Thinking of signing your company up for DrugPatentWatch? Read Post »
Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…
The post Finding and Evaluating Generic Drug Market Entry Opportunities appea…
Finding and Evaluating Generic Drug Market Entry Opportunities Read Post »
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…
The post Switching to DrugPatentWatch appeared fir…
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production of accurate, objective, and timely intelligence to help you quickly…
The post Automated Reports and Custom Dashboards appeared first…
DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when…
The post Customer Succe…
Customer Success: Will a generic version of a drug launch? And when? Read Post »
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…
The post Customer …
Customer Success: How do we identify generic entrants before they get FDA approval? Read Post »
Historic drug sales data can help with market sizing. By examining sales trends over time you can gauge the attractiveness of the market entry. For patented drugs examining sales trends…
The post How to Use Drug Sales Data to Refine Your Channel Strate…
In evaluating generic entry opportunities many factors must be considered. DrugPatentWatch has comprehensive resources to aid in evaluating patent and regulatory constraints, and those are described in further detail in…
The post How to Use Drug Price …
How to Use Drug Price Data for Generic Entry Pricing Read Post »
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
The post How Companies Can Extract Value from Expired Drug Patents appeared first on DrugPatentWatc…
How Companies Can Extract Value from Expired Drug Patents Read Post »